N-[4-(2-CHLORO-QUINOLIN-3-YL)-6-(2-HYDROXYPHENYL)-PYRIMIDIN-2-YL]-2-MORPHOLINO-ACETAMIDE
Compound with spectra: 1 NMR
![N-[4-(2-CHLORO-QUINOLIN-3-YL)-6-(2-HYDROXYPHENYL)-PYRIMIDIN-2-YL]-2-MORPHOLINO-ACETAMIDE](/api/compound/qnS6c8Z9Em.png?ph=true&h=300&w=458 "N-[4-(2-CHLORO-QUINOLIN-3-YL)-6-(2-HYDROXYPHENYL)-PYRIMIDIN-2-YL]-2-MORPHOLINO-ACETAMIDE")
| SpectraBase Compound ID | qnS6c8Z9Em |
|---|---|
| InChI | InChI=1S/C25H22ClN5O3/c26-24-18(13-16-5-1-3-7-19(16)27-24)21-14-20(17-6-2-4-8-22(17)32)28-25(29-21)30-23(33)15-31-9-11-34-12-10-31/h1-8,13-14,32H,9-12,15H2,(H,28,29,30,33) |
| InChIKey | UZMYZBRBOFDJMR-UHFFFAOYSA-N |
| Mol Weight | 475.94 g/mol |
| Molecular Formula | C25H22ClN5O3 |
| Exact Mass | 475.141117 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
N-[4-(2-CHLOROPHENYL)-6-(2-CHLORO-QUINOLIN-3-YL)-PYRIMIDIN-2-YL]-2-MORPHOLINO-ACETAMIDE
N-[4-(2-CHLORO-QUINOLIN-3-YL)-6-(3-FLUOROPHENYL)-PYRIMIDIN-2-YL]-2-MORPHOLINO-ACETAMIDE
4-Heptafluoropropyl-2-(2-naphthyl)quinoline
4-{[4-(4-fluorophenyl)-1-piperazinyl]carbonyl}-3-methyl-2-phenylquinoline
3-(1H-indol-2-yl)-2-phenyl-1H-indole
N-(1-benzyl-4-chloro-1H-pyrazol-3-yl)-2-(1-methyl-1H-pyrazol-4-yl)-4-quinolinecarboxamide
ethyl 2-({[2-(2-thienyl)-4-quinolinyl]carbonyl}amino)benzoate
1,3-Diazatricyclo[3.3.1.1(3,7)]decan-6-one, 5,7-dimethyl-2-[5-(4-morpholinylsulfonyl)-1H-indol-3-yl]-
2,21,23,42-Tetraoxa-1,22(1,3,4)-dibenzena-43(2,9)-1,10-phenanthrolinabicyclo[20.20.1]tritetracontaphane
N-{[2-(3-isobutoxyphenyl)-4-quinolinyl]carbonyl}-N'-(2-methyl-5-nitrophenyl)thiourea
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis, characterization and antimicrobial screening of hybrid molecules containing quinoline, pyrimidine and morpholine analogues | Journal of Chemical Sciences | 2013 |